Noninvasive Pulmonary Aspergillus Infections

Clinics in Chest Medicine

Volumn 30, Issue 2, 2009, Pages 315-335

  Riscili, Brent P ^a   Wood, Karen L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergilloma; Aspergillus; Chronic; Necrotizing

Indexed keywords

AMPHOTERICIN B; CLOTRIMAZOLE; CORTICOSTEROID; GAMMA INTERFERON; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; OMALIZUMAB; PNEUMOCOCCUS VACCINE; POSACONAZOLE; VORICONAZOLE;

ARTIFICIAL EMBOLISM; ASPERGILLOSIS; ASPERGILLUS; BRONCHOPULMONARY ASPERGILLOMA; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOGENESIS; INFECTION RISK; LABORATORY TEST; LUNG ASPERGILLOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

HUMANS; PULMONARY ASPERGILLOSIS;

EID: 64249130964     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2009.02.008     Document Type: Review

References (192)

1. Hohl T.M., and Feldmesser M. Aspergillus fumigatus: principles of pathogenesis and host defense. Eukaryot Cell 6 11 (2007) 1953-1963
2. Latge J.P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12 2 (1999) 310-350
3. Soubani A.O., and Chandrasekar P.H. The clinical spectrum of pulmonary aspergillosis. Chest 121 6 (2002) 1988-1999
4. Hinson K.F., Moon A.J., and Plummer N.S. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax 7 4 (1952) 317-333
5. Denning D.W., O'Driscoll B.R., Hogaboam C.M., et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27 3 (2006) 615-626
6. Stevens D.A., Moss R.B., Kurup V.P., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 37 Suppl 3 (2003) S225-S264
7. Greenberger P.A., Smith L.J., Hsu C.C., et al. Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: divergent responses of antigen-specific antibodies and total IgE. J Allergy Clin Immunol 82 2 (1988) 164-170
8. Eaton T., Garrett J., Milne D., et al. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 118 1 (2000) 66-72
9. Schwartz H.J., and Greenberger P.A. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 117 2 (1991) 138-142
10. Henderson A.H. Allergic aspergillosis: review of 32 cases. Thorax 23 5 (1968) 501-512
11. Moss R.B. Allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol 23 1 (2002) 87-104
12. Glancy J.J., Elder J.L., and McAleer R. Allergic bronchopulmonary fungal disease without clinical asthma. Thorax 36 5 (1981) 345-349
13. Judson M.A. Noninvasive Aspergillus pulmonary disease. Semin Respir Crit Care Med 25 2 (2004) 203-219
14. Slavin R.G., Bedrossian C.W., Hutcheson P.S., et al. A pathologic study of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 81 4 (1988) 718-725
15. Tillie-Leblond I., and Tonnel A.B. Allergic bronchopulmonary aspergillosis. Allergy 60 8 (2005) 1004-1013
16. Graves T.S., Fink J.N., Patterson R., et al. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med 91 3 (1979) 378-382
17. Halwig J.M., Kurup V.P., Greenberger P.A., et al. A familial occurrence of allergic bronchopulmonary aspergillosis: a probable environmental source. J Allergy Clin Immunol 76 1 (1985) 55-59
18. Chauhan B., Santiago L., Kirschmann D.A., et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 159 8 (1997) 4072-4076
19. Chauhan B., Santiago L., Hutcheson P.S., et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 106 4 (2000) 723-729
20. Khan M.A., Mathieu A., Sorrentino R., et al. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 6 3 (2007) 183-189
21. Wen L., Wong F.S., Tang J., et al. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med 191 1 (2000) 97-104
22. Raju R., Munn S.R., and David C.S. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum Immunol 58 1 (1997) 21-29
23. Chauhan B., Hutcheson P.S., Slavin R.G., et al. MHC restriction in allergic bronchopulmonary aspergillosis. Front Biosci 8 (2003) s140-s148
24. Miller P.W., Hamosh A., Macek Jr. M., et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 59 1 (1996) 45-51
25. Marchand E., Verellen-Dumoulin C., Mairesse M., et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 119 3 (2001) 762-767
26. Saxena S., Madan T., Shah A., et al. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 111 5 (2003) 1001-1007
27. Chauhan B., Knutsen A., Hutcheson P.S., et al. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 97 10 (1996) 2324-2331
28. Berkin K.E., Vernon D.R., and Kerr J.W. Lung collapse caused by allergic bronchopulmonary aspergillosis in non-asthmatic patients. Br Med J (Clin Res Ed) 285 6341 (1982) 552-553
29. Schubert M.S. Allergic fungal sinusitis. Clin Rev Allergy Immunol 30 3 (2006) 205-216
30. Braun J.J., Pauli G., Schultz P., et al. Allergic fungal sinusitis associated with allergic bronchopulmonary aspergillosis: an uncommon sinobronchial allergic mycosis. Am J Rhinol 21 4 (2007) 412-416
31. deShazo R.D., Chapin K., and Swain R.E. Fungal sinusitis. N Engl J Med 337 4 (1997) 254-259
32. Sher T.H., and Schwartz H.J. Allergic Aspergillus sinusitis with concurrent allergic bronchopulmonary Aspergillus: report of a case. J Allergy Clin Immunol 81 5 Pt 1 (1988) 844-846
33. Grammer L.C., Greenberger P.A., and Patterson R. Allergic bronchopulmonary aspergillosis in asthmatic patients presenting with allergic rhinitis. Int Arch Allergy Appl Immunol 79 3 (1986) 246-248
34. Knutsen A.P., Bellone C., and Kauffman H. Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis. J Cyst Fibros 1 2 (2002) 76-89
35. Beaumont F., Kauffman H.F., van der Mark T.H., et al. Volumetric aerobiological survey of conidial fungi in the North-East Netherlands. I. Seasonal patterns and the influence of meteorological variables. Allergy 40 3 (1985) 173-180
36. Robertson M.D., Seaton A., Milne L.J., et al. Suppression of host defences by Aspergillus fumigatus. Thorax 42 1 (1987) 19-25
37. Robertson M.D., Seaton A., Milne L.J., et al. Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. Thorax 42 6 (1987) 466-472
38. Roilides E., Uhlig K., Venzon D., et al. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 61 11 (1993) 4870-4877
39. Fraser R.S. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 28 Pt 1 (1993) 231-277
40. Kauffman H.F., Tomee J.F., van der Werf T.S., et al. Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 151 6 (1995) 2109-2115 [discussion: 2116]
41. Kauffman H.F. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci 8 (2003) e190-e196
42. Tomee J.F., Wierenga A.T., Hiemstra P.S., et al. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176 1 (1997) 300-303
43. Kauffman H.F., Tomee J.F., van de Riet M.A., et al. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 105 6 Pt 1 (2000) 1185-1193
44. Malo J.L., Inouye T., Hawkins R., et al. Studies in chronic allergic bronchopulmonary aspergillosis. 4. Comparison with a group of asthmatics. Thorax 32 3 (1977) 275-280
45. McCarthy D.S., and Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy 1 4 (1971) 415-432
46. Gibson P.G., Wark P.A., Simpson J.L., et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 21 4 (2003) 582-588
47. Malo J.L., Hawkins R., and Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings. Thorax 32 3 (1977) 254-261
48. Vlahakis N.E., and Aksamit T.R. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 76 9 (2001) 930-938
49. Schuyler M.R. Allergic bronchopulmonary aspergillosis. Clin Chest Med 4 1 (1983) 15-22
50. Wark P.A., Saltos N., Simpson J., et al. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 16 6 (2000) 1095-1101
51. Chu H.W., Wang J.M., Boutet M., et al. Immunohistochemical detection of GM-CSF, IL-4 and IL-5 in a murine model of allergic bronchopulmonary aspergillosis. Clin Exp Allergy 26 4 (1996) 461-468
52. Schuyler M. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 131 3 (1998) 194-196
53. Kurup V.P., Grunig G., Knutsen A.P., et al. Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol 149 4-5 (1998) 466-477 [discussion: 515-466]
54. Berger A. Th1 and Th2 responses: what are they?. BMJ 321 7258 (2000) 424
55. Knutsen A.P., Mueller K.R., Levine A.D., et al. Asp f I CD4 + TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 94 2 Pt 1 (1994) 215-221
56. Khan S., McClellan J.S., and Knutsen A.P. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Immunol 123 4 (2000) 319-326
57. Moss R.B. Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med Mycol 43 Suppl 1 (2005) S203-S206
58. Greenberger P.A., Liotta J.L., and Roberts M. The effects of age on isotypic antibody responses to Aspergillus fumigatus: implications regarding in vitro measurements. J Lab Clin Med 114 3 (1989) 278-284
59. Patterson R., Rosenberg M., and Roberts M. Evidence that Aspergillus fumigatus growing in the airway of man can be a potent stimulus of specific and nonspecific IgE formation. Am J Med 63 2 (1977) 257-262
60. Knutsen A.P. Lymphocytes in allergic bronchopulmonary aspergillosis. Front Biosci 8 (2003) d589-d602
61. Knutsen A.P., Hutchinson P.S., Albers G.M., et al. Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 59 1 (2004) 81-87
62. Schuh J.M., Blease K., Kunkel S.L., et al. Chemokines and cytokines: axis and allies in asthma and allergy. Cytokine Growth Factor Rev 14 6 (2003) 503-510
63. Grunig G., and Kurup V.P. Animal models of allergic bronchopulmonary aspergillosis. Front Biosci 8 (2003) e157-e171
64. Kradin R.L., and Mark E.J. The pathology of pulmonary disorders due to Aspergillus spp. Arch Pathol Lab Med 132 4 (2008) 606-614
65. Jelihovsky T. The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma. Histopathology 7 2 (1983) 153-167
66. Bosken C.H., Myers J.L., Greenberger P.A., et al. Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 12 3 (1988) 216-222
67. Zander D.S. Allergic bronchopulmonary aspergillosis: an overview. Arch Pathol Lab Med 129 7 (2005) 924-928
68. Zmeili O.S., and Soubani A.O. Pulmonary aspergillosis: a clinical update. QJM 100 6 (2007) 317-334
69. Rosenberg I.L., and Greenberger P.A. Allergic bronchopulmonary aspergillosis and aspergilloma. Long-term follow-up without enlargement of a large multiloculated cavity. Chest 85 1 (1984) 123-125
70. Safirstein B.H., D'Souza M.F., Simon G., et al. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 108 3 (1973) 450-459
71. Slavin R.G., Hutcheson P.S., Chauhan B., et al. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 25 6 (2004) 395-399
72. Malo J.L., Longbottom J., Mitchell J., et al. Studies in chronic allergic bronchopulmonary aspergillosis. 3. Immunological findings. Thorax 32 3 (1977) 269-274
73. Greenberger P.A. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110 5 (2002) 685-692
74. Schwartz H.J., Citron K.M., Chester E.H., et al. A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol 62 1 (1978) 9-14
75. Bahous J., Malo J.L., Paquin R., et al. Allergic bronchopulmonary aspergillosis and sensitization to Aspergillus fumigatus in chronic bronchiectasis in adults. Clin Allergy 15 6 (1985) 571-579
76. McCarthy D.S., Simon G., and Hargreave F.E. The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol 21 4 (1970) 366-375
77. Neeld D.A., Goodman L.R., Gurney J.W., et al. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 142 5 (1990) 1200-1205
78. Malo J.L., Pepys J., and Simon G. Studies in chronic allergic bronchopulmonary aspergillosis. 2. Radiological findings. Thorax 32 3 (1977) 262-268
79. Buckingham S.J., and Hansell D.M. Aspergillus in the lung: diverse and coincident forms. Eur Radiol 13 8 (2003) 1786-1800
80. Angus R.M., Davies M.L., Cowan M.D., et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 49 6 (1994) 586-589
81. Ward S., Heyneman L., Lee M.J., et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 173 4 (1999) 937-942
82. Franquet T., Muller N.L., Gimenez A., et al. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 21 4 (2001) 825-837
83. Currie D.C., Goldman J.M., Cole P.J., et al. Comparison of narrow section computed tomography and plain chest radiography in chronic allergic bronchopulmonary aspergillosis. Clin Radiol 38 6 (1987) 593-596
84. Sandhu M., Mukhopadhyay S., and Sharma S.K. Allergic bronchopulmonary aspergillosis: a comparative evaluation of computed tomography with plain chest radiography. Australas Radiol 38 4 (1994) 288-293
85. Cortese G., Malfitana V., Placido R., et al. Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis. Radiol Med 112 5 (2007) 626-636
86. Nichols D., Dopico G.A., Braun S., et al. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med 67 4 (1979) 631-637
87. Kraemer R., Delosea N., Ballinari P., et al. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 174 11 (2006) 1211-1220
88. Patterson R., Greenberger P.A., Radin R.C., et al. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 96 3 (1982) 286-291
89. Patterson R., Greenberger P.A., Halwig J.M., et al. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146 5 (1986) 916-918
90. Greenberger P.A., Miller T.P., Roberts M., et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 70 4 (1993) 333-338
91. Hoehne J.H., Reed C.E., and Dickie H.A. Allergic bronchopulmonary aspergillosis is not rare. With a note on preparation of antigen for immunologic tests. Chest 63 2 (1973) 177-181
92. Nguyen M.H., Jaber R., Leather H.L., et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 45 9 (2007) 2787-2792
93. Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 98 10 (2004) 915-923
94. Nikolaizik W.H., Moser M., Crameri R., et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 152 2 (1995) 634-639
95. Zeaske R., Bruns W.T., Fink J.N., et al. Immune responses to Aspergillus in cystic fibrosis. J Allergy Clin Immunol 82 1 (1988) 73-77
96. Hutcheson P.S., Rejent A.J., and Slavin R.G. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol 88 3 Pt 1 (1991) 390-394
97. de Oliveira E., Giavina-Bianchi P., Fonseca L.A., et al. Allergic bronchopulmonary aspergillosis' diagnosis remains a challenge. Respir Med 101 11 (2007) 2352-2357
98. Kurup V.P. Aspergillus antigens: which are important?. Med Mycol 43 Suppl 1 (2005) S189-S196
99. Banerjee B., Kurup V.P., Greenberger P.A., et al. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA). Clin Exp Allergy 31 5 (2001) 761-770
100. Hemmann S., Menz G., Ismail C., et al. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 104 3 Pt 1 (1999) 601-607
101. Knutsen A.P., Hutcheson P.S., Slavin R.G., et al. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 59 2 (2004) 198-203
102. Kurup V.P., Banerjee B., Hemmann S., et al. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 30 7 (2000) 988-993
103. Crameri R., Hemmann S., Ismail C., et al. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 10 8 (1998) 1211-1216
104. Kurup V.P., Knutsen A.P., Moss R.B., et al. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol Allergy 4 (2006) 11
105. Greenberger P.A., and Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy 56 6 (1986) 444-448
106. Lee T.M., Greenberger P.A., Patterson R., et al. Stage V (fibrotic) allergic bronchopulmonary aspergillosis. A review of 17 cases followed from diagnosis. Arch Intern Med 147 2 (1987) 319-323
107. van der Ent C.K., Hoekstra H., and Rijkers G.T. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 62 3 (2007) 276-277
108. Zirbes J.M., and Milla C.E. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 43 6 (2008) 607-610
109. Capewell S., Chapman B.J., Alexander F., et al. Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax 44 11 (1989) 925-929
110. Wark P.A., and Gibson P.G. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 6 1 (2001) 1-7
111. Wang J.L., Patterson R., Roberts M., et al. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 120 1 (1979) 87-92
112. Rosenberg M., Patterson R., Roberts M., et al. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 64 4 (1978) 599-606
113. Ricketti A.J., Greenberger P.A., and Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74 1 (1984) 68-71
114. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Report to the Research Committee of the British Thoracic Association. Br J Dis Chest 73 4 (1979) 349-356
115. Hilton A.M., and Chatterjee S.S. Bronchopulmonary aspergillosis-treatment with beclomethasone dipropionate. Postgrad Med J 51 Suppl 4 (1975) 98-103
116. Seaton A., Seaton R.A., and Wightman A.J. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow-up. QJM 87 9 (1994) 529-537
117. Thomson J.M., Wesley A., Byrnes C.A., et al. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulmonol 41 2 (2006) 164-170
118. Salez F., Brichet A., Desurmont S., et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 116 6 (1999) 1665-1668
119. Stevens D.A., Schwartz H.J., Lee J.Y., et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 342 11 (2000) 756-762
120. Leon E.E., and Craig T.J. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 82 6 (1999) 511-516 quiz 516-9
121. Shale D.J., Faux J.A., and Lane D.J. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 42 1 (1987) 26-31
122. Wark P.A., Hensley M.J., Saltos N., et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 111 5 (2003) 952-957
123. Saag M.S., and Dismukes W.E. Azole antifungal agents: emphasis on new triazoles. Antimicrobial Agents Chemother 32 1 (1988) 1-8
124. Wark P.A., Gibson P.G., and Wilson A.J. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 3 (2003) CD001108
125. Denning D.W., Van Wye J.E., Lewiston N.J., et al. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100 3 (1991) 813-819
126. Mannes G.P., van der Heide S., van Aalderen W.M., et al. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet 341 8843 (1993) 492
127. Nepomuceno I.B., Esrig S., and Moss R.B. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 115 2 (1999) 364-370
128. Skov M., Main K.M., Sillesen I.B., et al. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 20 1 (2002) 127-133
129. Zonios D.I., and Bennett J.E. Update on azole antifungals. Semin Respir Crit Care Med 29 2 (2008) 198-210
130. Hilliard T., Edwards S., Buchdahl R., et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 4 4 (2005) 215-220
131. Lazarus A.A., Thilagar B., and McKay S.A. Allergic bronchopulmonary aspergillosis. Dis Mon 54 8 (2008) 547-564
132. Mastella G., Rainisio M., Harms H.K., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 16 3 (2000) 464-471
133. Kurup V.P., and Grunig G. Animal models of allergic bronchopulmonary aspergillosis. Mycopathologia 153 4 (2002) 165-177
134. Shah R., Vaideeswar P., and Pandit S.P. Pathology of pulmonary aspergillomas. Indian J Pathol Microbiol 51 3 (2008) 342-345
135. Hours S., Nunes H., Kambouchner M., et al. Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis. Medicine (Baltimore) 87 3 (2008) 142-151
136. Sarosi G.A., Silberfarb P.M., Saliba N.A., et al. Aspergillomas occurring in blastomycotic cavities. Am Rev Respir Dis 104 4 (1971) 581-584
137. Kawamura S., Maesaki S., Tomono K., et al. Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med 39 3 (2000) 209-212
138. Rafferty P., Biggs B.A., Crompton G.K., et al. What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax 38 8 (1983) 579-583
139. Belcher J.R., and Plummer N.S. Surgery in broncho-pulmonary aspergillosis. Br J Dis Chest 54 (1960) 335-341
140. Walsh T.J., Anaissie E.J., Denning D.W., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 3 (2008) 327-360
141. Jewkes J., Kay P.H., Paneth M., et al. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 38 8 (1983) 572-578
142. Aspergilloma and residual tuberculous cavities-the results of a resurvey. Tubercle 51 3 (1970) 227-245
143. Chatzimichalis A., Massard G., Kessler R., et al. Bronchopulmonary aspergilloma: a reappraisal. Ann Thorac Surg 65 4 (1998) 927-929
144. Ueda H., Okabayashi K., Ondo K., et al. Analysis of various treatments for pulmonary aspergillomas. Surg Today 31 9 (2001) 768-773
145. Kibbler C.C., Milkins S.R., Bhamra A., et al. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 43 2 (1988) 108-112
146. Addrizzo-Harris D.J., Harkin T.J., McGuinness G., et al. Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals. Chest 111 3 (1997) 612-618
147. Westney G.E., Kesten S., De Hoyos A., et al. Aspergillus infection in single and double lung transplant recipients. Transplantation 61 6 (1996) 915-919
148. Denning D.W. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 7 Suppl 2 (2001) 25-31
149. Campbell J.H., Winter J.H., Richardson M.D., et al. Treatment of pulmonary aspergilloma with itraconazole. Thorax 46 11 (1991) 839-841
150. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 23 3 Pt 2 (1990) 607-614
151. Al-Kattan K., Ashour M., Hajjar W., et al. Surgery for pulmonary aspergilloma in post-tuberculous vs. immuno-compromised patients. Eur J Cardiothorac Surg 20 4 (2001) 728-733
152. Baron O., Guillaume B., Moreau P., et al. Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: report of eighteen cases. J Thorac Cardiovasc Surg 115 1 (1998) 63-68 [discussion: 68-9]
153. Danner B.C., Didilis V., Dorge H., et al. Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients. Interact Cardiovasc Thorac Surg 7 5 (2008) 771-776
154. Brik A., Salem A.M., Kamal A.R., et al. Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg 34 4 (2008) 882-885
155. Okubo K., Kobayashi M., Morikawa H., et al. Favorable acute and long-term outcomes after the resection of pulmonary aspergillomas. Thorac Cardiovasc Surg 55 2 (2007) 108-111
156. Endo S., Otani S., Tezuka Y., et al. Predictors of postoperative complications after radical resection for pulmonary aspergillosis. Surg Today 36 6 (2006) 499-503
157. Shiraishi Y., Katsuragi N., Nakajima Y., et al. Pneumonectomy for complex aspergilloma: is it still dangerous?. Eur J Cardiothorac Surg 29 1 (2006) 9-13
158. Kim Y.T., Kang M.C., Sung S.W., et al. Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma. Ann Thorac Surg 79 1 (2005) 294-298
159. Akbari J.G., Varma P.K., Neema P.K., et al. Clinical profile and surgical outcome for pulmonary aspergilloma: a single center experience. Ann Thorac Surg 80 3 (2005) 1067-1072
160. Park C.K., and Jheon S. Results of surgical treatment for pulmonary aspergilloma. Eur J Cardiothorac Surg 21 5 (2002) 918-923
161. Babatasi G., Massetti M., Chapelier A., et al. Surgical treatment of pulmonary aspergilloma: current outcome. J Thorac Cardiovasc Surg 119 5 (2000) 906-912
162. Regnard J.F., Icard P., Nicolosi M., et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg 69 3 (2000) 898-903
163. Kato A., Kudo S., Matsumoto K., et al. Bronchial artery embolization for hemoptysis due to benign diseases: immediate and long-term results. Cardiovasc Intervent Radiol 23 5 (2000) 351-357
164. Kim Y.G., Yoon H.K., Ko G.Y., et al. Long-term effect of bronchial artery embolization in Korean patients with haemoptysis. Respirology 11 6 (2006) 776-781
165. Corr P. Management of severe hemoptysis from pulmonary aspergilloma using endovascular embolization. Cardiovasc Intervent Radiol 29 5 (2006) 807-810
166. Rumbak M., Kohler G., Eastrige C., et al. Topical treatment of life threatening haemoptysis from aspergillomas. Thorax 51 3 (1996) 253-255
167. Munk P.L., Vellet A.D., Rankin R.N., et al. Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin gelatin solution. Radiology 188 3 (1993) 821-823
168. Hargis J.L., Bone R.C., Stewart J., et al. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med 68 3 (1980) 389-394
169. Krakowka P., Traczyk K., Walczak J., et al. Local treatment of aspergilloma of the lung with a paste containing nystatin or amphotericin B. Tubercle 51 2 (1970) 184-191
170. Jackson M., Flower C.D., and Shneerson J.M. Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax 48 9 (1993) 928-930
171. Giron J., Poey C., Fajadet P., et al. CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol 28 3 (1998) 235-242
172. Denning DW. Aspergillosis. In: Fauci AS, Kasper DL, Longo DL, et al, editors. Harrison's principles of internal medicine. 17th edition. USA: The McGraw-Hill Companies, Inc.; 2008. Available at. http://online.statref.com/document.aspx?fxid=55&docid=1616. November 11, 2008.
173. Binder R.E., Faling L.J., Pugatch R.D., et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 61 2 (1982) 109-124
174. Gefter W.B., Weingrad T.R., Epstein D.M., et al. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. Radiology 140 2 (1981) 313-321
175. Kato T., Usami I., Morita H., et al. Chronic necrotizing pulmonary aspergillosis in pneumoconiosis: clinical and radiologic findings in 10 patients. Chest 121 1 (2002) 118-127
176. Denning D.W., Riniotis K., Dobrashian R., et al. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37 Suppl 3 (2003) S265-S280
177. Vaid M., Kaur S., Sambatakou H., et al. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 45 2 (2007) 183-186
178. Carvalho A., Pasqualotto A.C., Pitzurra L., et al. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 197 4 (2008) 618-621
179. Crosdale D.J., Poulton K.V., Ollier W.E., et al. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 184 5 (2001) 653-656
180. Saraceno J.L., Phelps D.T., Ferro T.J., et al. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 112 2 (1997) 541-548
181. Kobashi Y., Fukuda M., Yoshida K., et al. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology 11 6 (2006) 809-813
182. Kitazaki T., Osumi M., Miyazaki Y., et al. Chronic necrotizing pulmonary aspergillosis following cryptococcal infection of the lung. Scand J Infect Dis 37 5 (2005) 393-395
183. Franquet T., Muller N.L., Gimenez A., et al. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients. AJR Am J Roentgenol 174 1 (2000) 51-56
184. Kim S.Y., Lee K.S., Han J., et al. Semiinvasive pulmonary aspergillosis: CT and pathologic findings in six patients. AJR Am J Roentgenol 174 3 (2000) 795-798
185. Thompson B.H., Stanford W., Galvin J.R., et al. Varied radiologic appearances of pulmonary aspergillosis. Radiographics 15 6 (1995) 1273-1284
186. Caras W.E. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 113 3 (1998) 852-853
187. Yousem S.A. The histological spectrum of chronic necrotizing forms of pulmonary aspergillosis. Hum Pathol 28 6 (1997) 650-656
188. Camuset J., Nunes H., Dombret M.C., et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 131 5 (2007) 1435-1441
189. Sambatakou H, Dupont B, Lode H, et al. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med 2006;119(6):527, e517-24
190. Jain L.R., and Denning D.W. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect 52 5 (2006) e133-e137
191. Kelleher P., Goodsall A., Mulgirigama A., et al. Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis. Eur Respir J 27 6 (2006) 1307-1310
192. Endo S., Sohara Y., Murayama F., et al. Surgical outcome of pulmonary resection in chronic necrotizing pulmonary aspergillosis. Ann Thorac Surg 72 3 (2001) 889-893 [discussion: 894]